How Much Did Hualan Biological Engineering Raise?
Funding & Key Investors

Hualan Biological Engineering has solidified its market position through a significant capital infusion, securing a total of $292M in cumulative financing. This latest development, marked by a $292M strategic investment, underscores the firm's robust trajectory within the biopharmaceutical sector. By leveraging this influx of capital, the organization is poised to accelerate its operational capabilities and expand its footprint in the highly regulated biological manufacturing landscape.

The recent financing round reflects strong institutional confidence in the company's long-term value proposition. As Hualan Biological Engineering continues to navigate the complexities of global health standards, this financial backing serves as a critical catalyst for scaling its integrated quality assurance systems and enhancing its competitive edge in the international market.

What is Hualan Biological Engineering?

Hualan Biological Engineering
ManufacturingChemicals & Related ProductsPharmaceuticals

Hualan Biological Engineering Inc. operates as a sophisticated biopharmaceutical entity, specializing in the development and production of biological products. The company maintains a rigorous focus on quality management, utilizing an integrated QA system that spans from raw material procurement to final drug distribution. By adhering to stringent GMP compliance standards and proactively adopting EU-level management frameworks, Hualan has established itself as a leader in drug stability and quality risk assessment. Its commitment to independent quality supervision and continuous process validation ensures that its manufacturing operations remain in a validated state, effectively mitigating risks associated with contamination and production variability.

How much funding has Hualan Biological Engineering raised?

Hualan Biological Engineering has raised a total of $292M across 1 funding round:

2020

Other Financing Round

$292M

Other Financing Round (2020): $292M with participation from Lin Xiaodan and Hillhouse Capital

Key Investors in Hualan Biological Engineering

Hillhouse Capital

Hillhouse Capital is an Asia focused global private investment firm. The company was founded in 2005 and is based out of Hong Kong, Beijing, and Singapore.

Lin Xiaodan

Individual investor participating in the strategic financing round.

What's next for Hualan Biological Engineering?

With the recent capital injection, Hualan Biological Engineering is strategically positioned to deepen its investment in advanced manufacturing infrastructure and regulatory compliance. The company is expected to leverage these resources to further refine its quality management systems, potentially aligning its production workshops with even more stringent international benchmarks. As the firm scales, the focus will likely shift toward expanding its product pipeline and strengthening its supply chain resilience. This strategic growth phase is essential for maintaining its status as a premier provider of biological therapeutics, ensuring that the company remains at the forefront of innovation while meeting the evolving demands of global healthcare markets.

See full Hualan Biological Engineering company page
See More Financial Insights
No matching results.
Refine your search.

Additional financial insights in the Manufacturing industry

ManufacturingMedical Devices & EquipmentIndustrial Machinery & Equipment
Industrial Machinery & EquipmentManufacturingRetailOther Rental Stores (Furniture, A/V, Construction & Industrial Equipment)
FurnitureManufacturing
Building MaterialsManufacturingFurniture

Frequently Asked Questions Regarding Hualan Biological Engineering Financial Insights

What are the most recent funding rounds that Hualan Biological Engineering has completed, and what were the funding rounds?
Hualan Biological Engineering has recently completed 1 funding rounds: Other Financing Round on Mar 30, 2020.
What is the total amount of funding Hualan Biological Engineering has raised to date?
Hualan Biological Engineering has raised a total of $292M in funding to date.
How many funding rounds has Hualan Biological Engineering completed?
Hualan Biological Engineering has completed 1 funding rounds.
How much funding did Hualan Biological Engineering raise in its most recent funding round?
Hualan Biological Engineering raised $292M in its most recent funding round.
Who are the lead investors in Hualan Biological Engineering's latest funding round?
The lead investor in Hualan Biological Engineering's latest funding round was Lin Xiaodan. To access investor data and explore similar companies, sign up for ZoomInfo.
Which was the largest funding round in Hualan Biological Engineering's history?
The largest funding round in Hualan Biological Engineering's history was $292M.
See more information about Hualan Biological Engineering